| 中國醫藥大學 |
2007-05 |
Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction
|
侯庭鏞(Tin-Yun Ho);吳世祿(Shih-Lu Wu);陳兆群(Jaw-Chyun Chen);李佳橙(Chia-Cheng Li);項千芸(Chien-Yun Hsiang)* |
| 臺北醫學大學 |
2018 |
Emodin derivatives inhibit the growth and invasion of human malignant glioma cells
|
Kang, Shuo-Jhen; 康碩珍 |
| 亞洲大學 |
2005-03 |
Emodin downregulates androgen receptor and inhibits prostate cancer cell growth
|
Cha, T-L.;Qiu, L.;Chun-Te Chen;Wem, Y;Mien-Chie Hung |
| 臺大學術典藏 |
2018-09-10T08:09:11Z |
Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2
|
Ko, J.-C. and Su, Y.-J. and Lin, S.-T. and Jhan, J.-Y. and Ciou, S.-C. and Cheng, C.-M. and Chiu, Y.-F. and Kuo, Y.-H. and Tsai, M.-S. and Lin, Y.-W.; JEN-CHUNG KO; Su, Ying-Jhen; Lin, Szu-Ting; Jhan, Jhih-Yuan; Ciou, Shih-Ci; Cheng, Chao-Min; Chiu, Yu-Fan; Kuo, Ya-Hsun; Tsai, Min-Shao; Lin, Yun-Wei |
| 臺大學術典藏 |
2021-03-11T08:29:41Z |
Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2
|
Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Chiu Y.-F.;Kuo Y.-H.;Tsai M.-S.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W. |
| 臺大學術典藏 |
2021-10-04T07:15:51Z |
Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2
|
JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:36Z |
Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2
|
Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Chiu Y.-F.;Kuo Y.-H.;Tsai M.-S.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:34:28Z |
Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2
|
Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Chiu Y.-F.;Kuo Y.-H.;Tsai M.-S.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:37Z |
Emodin enhances gefitinib-induced cytotoxicity via Rad51 downregulation and ERK1/2 inactivation
|
Chen R.-S.; Jhan J.-Y.; Su Y.-J.; Lee W.-T.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Chuang S.-M.; JEN-CHANG KO; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:29:41Z |
Emodin enhances gefitinib-induced cytotoxicity via Rad51 downregulation and ERK1/2 inactivation
|
Chen R.-S.; Jhan J.-Y.; Su Y.-J.; Lee W.-T.; Cheng C.-M.; Ciou S.-C.; Lin S.-T.; Chuang S.-M.; JEN-CHANG KO; Lin Y.-W. |
